Punit Dhillon is Chief Executive Officer of Skye Bioscience, Inc.. Currently has a direct ownership of 412,733 shares of SKYE, which is worth approximately $2.39 Million. The most recent transaction as insider was on Aug 26, 2024, when has been sold 15,727 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 413K
3.96% 3M change
38.96% 12M change
Total Value Held $2.39 Million

PUNIT DHILLON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 26 2024
BUY
Other acquisition or disposition
-
15,727 Added 3.67%
412,733 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
-
100,000 Added 20.12%
397,006 Common Stock
Nov 06 2023
BUY
Grant, award, or other acquisition
-
194,270 Added 39.54%
297,006 Common Stock
Aug 29 2023
BUY
Open market or private purchase
$17,620 $0.02 p/Share
881,000 Added 2.08%
41,554,828 Common Stock
Aug 28 2023
BUY
Small Acquisition
$2,200 $0.02 p/Share
110,000 Added 0.27%
40,673,828 Common Stock
Aug 25 2023
BUY
Grant, award, or other acquisition
-
20,277,414 Added 33.33%
40,554,828 Common Stock
Aug 23 2023
BUY
Small Acquisition
$90 $0.01 p/Share
9,000 Added 0.02%
40,563,828 Common Stock
Nov 10 2022
BUY
Grant, award, or other acquisition
-
1,406,543 Added 24.2%
4,406,543 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
2,000,000 Added 40.0%
3,000,000 Common Stock

Also insider at

ARTH
Arch Therapeutics, Inc. Healthcare
PD

Punit Dhillon

Chief Executive Officer
Framingham, MA

Track Institutional and Insider Activities on SKYE

Follow Skye Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SKYE shares.

Notify only if

Insider Trading

Get notified when an Skye Bioscience, Inc. insider buys or sells SKYE shares.

Notify only if

News

Receive news related to Skye Bioscience, Inc.

Track Activities on SKYE